Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CELLg8 is a market-leading biotechnology and contract manufacturing company specializing in advanced liposomal delivery systems for the nutraceutical and supplement industries. Founded by Dr. Emek Blair, the company utilizes a proprietary, all-natural manufacturing process that requires no heat, high pressure, or toxic solvents to encapsulate active nutrients, vitamins, and botanicals in highly stable lipid bilayers. This technology, now in its eighth generation, has been clinically validated in multiple human trials to significantly enhance bioavailability and absorption rates (up to 15 to 20 times higher than standard oral supplements) while eliminating common digestive side effects. Operating out of cGMP-certified facilities in Colorado, CELLg8 provides scalable B2B private label manufacturing, custom formulations, and turnkey solutions for global health and wellness brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CELLg8.